Summary:
- Barcelona-based startup Biorce has raised €43.8 million in a Series A funding round to accelerate the development of its AI-powered platform for clinical trials.
- Biorce's platform uses advanced AI and machine learning algorithms to optimize the design and execution of clinical trials, making the process more efficient and cost-effective.
- The company plans to use the funding to expand its team, further develop its technology, and scale its operations to support more pharmaceutical and biotechnology companies in conducting successful clinical trials.